One of the world's leading hyaluronic acid dermal filler brands, developed by Allergan Aesthetics and used by dermatologists and plastic surgeons worldwide for over two decades.
JUVÉDERM® is a premium collection of injectable fillers designed for facial rejuvenation, contour enhancement, wrinkle correction, and volume restoration. Marketed in more than 100 countries with extensive regulatory approvals, including FDA approval for multiple indications in the United States.
A smooth monophasic gel with high cohesiveness, excellent injectability, and soft tissue integration for a natural appearance. Used in Ultra XC and Ultra Plus XC.
A newer technology blending high- and low-molecular-weight hyaluronic acid into a more efficient cross-linked gel, offering greater lifting capacity, lower water absorption, less post-treatment swelling, longer duration, and improved tissue integration. Used in Voluma XC, Volbella XC, Vollure XC, and Volux XC — one of JUVÉDERM's main differentiators from many competing HA fillers.
Lips, facial wrinkles (Hylacross)
Deep folds, volume (Hylacross)
Lips, perioral lines, under-eye hollows in some markets (VYCROSS)
Moderate-to-severe nasolabial folds (VYCROSS)
Cheeks, chin, temples (VYCROSS)
Jawline definition (VYCROSS)
Because these risks exist with any injectable or energy-based treatment, procedures should only be performed by trained, licensed medical professionals with expertise in facial anatomy.
JUVÉDERM has one of the strongest regulatory portfolios among dermal fillers: FDA-approved for multiple facial indications in the United States, authorized in Canada, CE marked and marketed across Europe, and approved in many countries throughout Asia, Latin America, and the Middle East. Approval status and specific indications vary by country.
JUVÉDERM is widely regarded as a gold standard in hyaluronic acid dermal fillers due to its extensive clinical evidence, proprietary cross-linking technologies, and broad portfolio of products tailored to specific facial regions. Compared with many newer filler brands, it benefits from decades of clinical use, multiple regulatory approvals, and well-established safety and efficacy data. Outcomes still depend heavily on injector expertise and individual patient factors.
